Rhia Ventures

Rhia Ventures is a San Francisco-based venture capital firm dedicated to advancing reproductive and maternal health equity by intentionally leveraging capital to center the needs, experiences, and perspectives of historically marginalized people in decision-making. The firm envisions a world where every woman and birthing person can thrive with full autonomy over their reproductive and maternal health, and where investment decisions are rooted in racial and gender equity. Their activities include systems change to build an inclusive women's reproductive and maternal health market, capital strategies to leverage private sector investment in women's health, and advising organizations, investors, and entrepreneurs on incorporating health equity and racial equity into their capital strategies.

The firm's investment strategy focuses on early-stage startups across all healthcare segments, including life sciences (diagnostics, devices, therapeutics), digital health, services, and consumer health. They particularly emphasize sectors such as contraception, maternal health, and other high-impact and underserved areas in women's health. Rhia Ventures operates RH Capital, an impact-first venture capital fund that invests in early-stage startups promising to revolutionize women's health and improve health equity in the United States. Underlying all of their work is a continued commitment to gender and racial equity.

Rhia Ventures has a track record of investing in companies that align with their mission. Notable portfolio companies include Eli, Twentyeight Health, AOA, YourChoice Therapeutics, Cayaba Care, Fogarty Institute of Innovation, Raydiant Oximetry, Testmate Health, Contraline, and Mae Health. These investments reflect the firm's dedication to supporting innovative solutions that empower women and address critical needs in reproductive and maternal health. Their approach combines financial support with strategic guidance to foster sustainable growth and impact in the healthcare sector.